Skip to main content
Deutsches Ärzteblatt International logoLink to Deutsches Ärzteblatt International
letter
. 2014 May 30;111(22):403–404. doi: 10.3238/arztebl.2014.0404

Correspondence (letter to the editor): In Reply

Günther Schellong *, Jürgen Brämswig *
PMCID: PMC4078231  PMID: 24980568

The authors of the article agree that a thorough family history is needed in female patients included in the screening program who are at high risk for developing breast cancer following treatment for Hodgkin's disease. The guidelines provide for an initial examination of young adult women at risk for breast cancer. However, there should be no delay in admitting patients as early as possible to the centers of the consortium for familial breast cancer even though the results of genetic counseling and investigations are not yet available. The necessary consultations can be performed in parallel to the breast cancer screening.

We also support Dr Tsamaloukas in advocating an effective follow-up for long-term survivors of malignancies. We published prospective findings of the incidence of breast cancer as one of the late effects of Hodgkin lymphoma treatment. (1). Additional publications have shown that long-term follow-up has been organized not only in the US but also in Germany, for pedriatric patients (24). The guidelines of the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF) by S. Schuster et al. give additional information for identification, prevention and treatment of children, adolescents, and young adults with cancer. This guideline introduces concepts for the immediate and long-term follow-up for these patients.

Footnotes

Conflict of interest statement

The authors of all contributions declare that no conflict of interest exists.

References

  • 1.Schellong G, Riepenhausen M, Ehlert K, et al. Breast cancer in young women after treatment for Hodgkin´s lymphoma during childhood or adolescence—an observational study with up to 33-year follow up. Dtsch Arztebl Int. 2014;111(1-2):3–9. doi: 10.3238/arztebl.2014.0003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schellong G, et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatric blood & cancer. 2010;55:1145–1152. doi: 10.1002/pbc.22664. [DOI] [PubMed] [Google Scholar]
  • 3.Schuck A, et al. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol. 2005;181:534–539. doi: 10.1007/s00066-005-9500-4. [DOI] [PubMed] [Google Scholar]
  • 4.Calaminus G, et al. Quality of life in long-term survivors following treatment for Hodgkin's disease during childhood and adolescence in the German multicentre studies between 1978 and 2002. Support Care Cancer. 2014;22:1519–1529. doi: 10.1007/s00520-013-2114-y. [DOI] [PubMed] [Google Scholar]

Articles from Deutsches Ärzteblatt International are provided here courtesy of Deutscher Arzte-Verlag GmbH

RESOURCES